Q2 2026 Sagility Ltd Earnings Call Transcript
Key Points
- Sagility Ltd (NSE:SAGILITY) reported a strong year-on-year revenue growth of 25.2% in INR terms and 20% in constant currency for Q2 FY26.
- The company achieved a robust EBITDA margin of 26.2%, reflecting strong operational execution and improved delivery efficiency.
- Sagility Ltd (NSE:SAGILITY) secured business from 24 existing clients and added 5 new clients, with an aggregate annual contract value of $34 million.
- The company has been recognized for its commitment to excellence, earning a 'Great Place to Work' certification in India and winning the Asia CEO Awards 2025 for service excellence.
- Sagility Ltd (NSE:SAGILITY) is leveraging AI and technology to drive efficiency and transformation, with 25 distinct AI use cases deployed across 9 clients.
- The broader US healthcare landscape faces challenges such as rising costs, shrinking margins, and growing regulatory complexity, impacting Sagility Ltd (NSE:SAGILITY)'s clients.
- The company's exposure to the ACA market is low, but there is a fear of reduced membership and premium inflows due to regulatory changes.
- The proposed 25% excise tax on outsourcing payments to foreign entities could impact margins if implemented, although its likelihood is considered low.
- Broadpath, a part of Sagility Ltd (NSE:SAGILITY), has lower margins compared to the rest of the company, which could dampen overall margins in Q3.
- There is ongoing pressure from clients to pass on productivity gains from AI, which could affect future revenue growth.
Good evening everyone and welcome to the quarter to H1 FY 26 earnings webinar of Sagility India Limited. This is Siddharth Rangnekar from CDR India, and I shall be your host today.(operator instructions). To introduce the management, we have with us Mr. Ramesh Gopalan. Managing director and group CEO Mr. Sarvabhouman Srinivasan, Group Chief Financial Officer. (operator instructions). I would now like to hand over the forum to Mr. Ramesh Gopalan to begin the proceedings of this webinar. Over to you.
Thank you Siddharth. Good evening, everyone, and welcome to our Q2 and H1 Fy26 discussion.
Let me give some opening remarks. In the first half of FY 26, we continue to demonstrate strong momentum across both payer and provider segments, underscoring the depth of our expertise and a proven ability to deliver at scale. The broader US healthcare landscape continues to face ongoing challenges from rising costs, shrinking margins, and growing regulatory complexity.
These
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
